Infectious Diseases and HIV Medicine
Publications
Preserved MHC class II antigen processing in monocytes from HIV-infected individuals
Preserved MHC class II antigen processing in monocytes from HIV-infected individuals
''Preserved MHC class II antigen processing in monocytes from HIV-infected individuals''
PLoS One. 2010 Mar 3
Woc-Colburn L, Smultea L, Ramachandra L, Canaday DH.
Division of Infectious Diseases and HIV Medicine, Case Western Reserve University School of Medicine, Cleveland
BACKGROUND :: MHC-II restricted CD4+ T cells are dependent on antigen presenting cells (APC) for their activation. APC dysfunction in HIV-infected individuals could accelerate or exacerbate CD4+ T cell dysfunction and may contribute to increased levels of immunodeficiency seen in some patients regardless of their CD4+ T cell numbers. Here we test the hypothesis that APC from HIV-infected individuals have diminished antigen processing and presentation capacity.
METHODOLOGY & PRINCIPAL FINDINGS :: Monocytes (MN) were purified by immuno-magnetic bead isolation techniques from HLA-DR1.01+ or DR15.01+ HIV-infected and uninfected individuals. MN were analyzed for surface MHC-II expression and for antigen processing and presentation capacity after overnight incubation with soluble antigen or peptide and HLA-DR matched T cell hybridomas. Surface expression of HLA-DR was 20% reduced (p<0.03) on MN from HIV-infected individuals. In spite of this, there was no significant difference in antigen processing and presentation by MN from 14 HIV-infected donors (8 HLA-DR1.01+ and 6 HLA-DR15.01+) compared to 24 HIV-uninfected HLA-matched subjects.
CONCLUSIONS :: We demonstrated that MHC class II antigen processing and presentation is preserved in MN from HIV-infected individuals. This further supports the concept that this aspect of APC function does not further contribute to CD4+ T cell dysfunction in HIV disease.

- Division Chief Message
- News
- Publications
- Penicillin sulfone inhibitors of class D beta-lactamases
- In vitro activity of penem-1 in combination with beta-lactams against blaKPC-possessing Klebsiella pneumoniae isolates.
- Evaluation of an alcohol-based power sanitizing system
- Saline Nebulization before Gastric Lavage in the Diagnosis of Pulmonary Tuberculosis in Children and Adolescents
- Preserved MHC class II antigen processing in monocytes from HIV-infected individuals
- Acinetobacter baumannii-associated skin and soft tissue infections
- Streptococcus anginosus Pyomyositis in a 50-Year-Old Man with Acquired Immunodeficiency Syndrome
- Antibiotic resistance determinants in Acinetobacter spp and clinical outcomes
- Influenza-Induced Production of Interferon-Alpha is Defective in Geriatric Individuals
- Enhancing resistance to cephalosporins in class C beta-lactamases
- Three decades of beta-lactamase inhibitors
- In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates
- Persistence of skin contamination & environmental shedding of Clostridium difficile
- Comparative description of haplotype structure and genetic diversity of MDR1
- Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design
- Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase
- Increased tissue factor expression on circulating monocytes in chronic HIV infection
- Faculty
- Research
- The Fight Against TB
- Patient Care
- Fellowship Program
- Contacts
